Lucrative Asia-Pacific Markets to Offer Significant Growth Opportunities for the Transfection Reagents and Equipment Market in the Coming Years

By -

This report studies the global transfection reagents and equipment market from 2016 to 2021.

(EMAILWIRE.COM, February 22, 2019 ) Growth in the Transfection Reagent Market is likely to be centered in the Asia-Pacific region. This growth can be attributed to growing economies such as China and India, growing R&D expenditure in Asian countries, and increasing medical research activities in the Asia-Pacific region.

Key players are focusing on the strategies of agreements, collaborations, and partnerships to excel in research & innovation, expand customer base, and enhance their sales & distribution network. Some of the key players that adopted this strategy include MaxCyte, Inc. (U.S.), Polyplus-transfection SA (France), and QIAGEN N.V. (Netherlands).

On the basis of product, the transfection reagents and equipment market is categorized into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.

On the basis of method, the market is segmented into biochemical, physical, and viral methods. In 2016, the biochemical method segment is expected to account for the largest share of the market, while the viral method segment is expected to grow at the highest CAGR during the forecast period.

Feel Free to Talk to Our Research Experts@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139141146

The biochemical method segment is further classified into calcium phosphate, lipofection, DEAE-Dextran, and dendrimers. Whereas, the physical method segment is further divided into electroporation, nucleofection, and others (gengun, sonoporation, magnetofection, and optoinjection).

On the basis of application, the market is segmented into biomedical research, protein production, and therapeutic delivery. In 2016, the biomedical research segment is estimated to account for the largest share of the market.

On the basis of end user, the market is segmented into academic & research institutes and pharmaceutical & biotechnologies companies. In 2016, the academic & research institutes is expected to account for the largest share of the market. However, the pharmaceutical & biotechnologies companies segment is projected to grow at the highest CAGR during the forecast period.

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Read the Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more